Immedica Pharma AB Sustainability Reports

Immedica Pharma AB is a pharmaceutical company focused on the commercialization and distribution of medicines for rare diseases and specialty care. Its capabilities cover market access, regulatory affairs, quality assurance, and compliance across Europe, the Middle East, and the United States.

Sector: Wholesale & retail

Country: Sweden

Exchange: Unlisted

LEI: 549300Q0QKHL3MF7FV02

3 reports from 2023 to 2025

• Immedica Pharma AB 2025 Slavery and Human Trafficking Statement
• Immedica Pharma AB 2025 Sustainability Report
• Immedica Pharma AB 2023 Business Review and Annual & Sustainability Report